GPT and metabolic dysfunction-associated steatotic liver disease: Indeed, in our investigations, the obese NAFLD patients met all the IDF/NHLBI/AHA-2009 criteria of MetS and the nonobese patients met only two, whereas liver cell necrosis (measured as ALT values) was comparable in both groups of the subjects.